Co-infection of HIV and HCV Among Patients Under Antiretroviral Treatment: Insights from Selected Healthcare Facilities in Ilorin, Nigeria - Summary - MDSpire
Advertisement
Co-infection of HIV and HCV Among Patients Under Antiretroviral Treatment: Insights from Selected Healthcare Facilities in Ilorin, Nigeria
To assess the prevalence of HIV/HCV co-infection and associated factors in people living with HIV (PLHIV) in Ilorin, Nigeria, highlighting the significance of this research in addressing the existing knowledge gap.
Key Findings:
HIV/HCV co-infection prevalence in Ilorin is currently unknown due to lack of recent data, which poses challenges for treatment and public health.
Previous studies reported varying prevalence rates of HIV/HCV co-infection in Nigeria, highlighting the need for updated research.
HIV/HCV co-infected patients face higher risks of liver disease and treatment complications.
Interpretation:
The study aims to fill the gap in knowledge regarding HIV/HCV co-infection prevalence in Ilorin, which is crucial for improving clinical care, adherence to national guidelines, and informing public health policy.
Limitations:
Study conducted in only two hospitals may not represent the entire population of PLHIV in Ilorin, potentially affecting the generalizability of the findings.
Convenient sampling method may introduce selection bias, impacting the reliability of the results.
Conclusion:
The findings will contribute to understanding the prevalence of HIV/HCV co-infection in Nigeria and emphasize the importance of HCV screening in PLHIV to enhance treatment outcomes, particularly in the context of ART.
